Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 199

    1.

    Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?

    Askling J, Sørensen P, Ekbom A, Frisch M, Melbye M, Glimelius B, Hjalgrim H.

    Ann Intern Med. 1999 Nov 2;131(9):655-9.PMID: 10577327 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma.

    Hjalgrim H, Frisch M, Storm HH, Glimelius B, Pedersen JB, Melbye M.

    Int J Cancer. 2000 Mar 1;85(5):639-42.PMID: 10699942 [PubMed - indexed for MEDLINE]Related articles

    3.

    Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?

    Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, Bruland OS, Moan J.

    Lung Cancer. 2007 Mar;55(3):263-70. Epub 2007 Jan 17.PMID: 17207891 [PubMed - indexed for MEDLINE]Related articles

    4.

    Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study.

    Frisch M, Hjalgrim H, Olsen JH, Melbye M.

    Ann Intern Med. 1996 Nov 15;125(10):815-21.PMID: 8928988 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.

    Rosenquist K.

    Swed Dent J Suppl. 2005;(179):1-66.PMID: 16335030 [PubMed - indexed for MEDLINE]Related articles

    6.

    Increased cancer mortality following a history of nonmelanoma skin cancer.

    Kahn HS, Tatham LM, Patel AV, Thun MJ, Heath CW Jr.

    JAMA. 1998 Sep 9;280(10):910-2.PMID: 9739976 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

    Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR.

    JAMA. 1996 Dec 25;276(24):1957-63. Erratum in: JAMA 1997 May 21;277(19):1520. PMID: 8971064 [PubMed - indexed for MEDLINE]Related articles

    8.

    Risk of second malignant neoplasms among lymphoma patients with a family history of cancer.

    Landgren O, Pfeiffer RM, Stewart L, Gridley G, Mellemkjaer L, Hemminki K, Goldin LR, Travis LB.

    Int J Cancer. 2007 Mar 1;120(5):1099-102.PMID: 17131330 [PubMed - indexed for MEDLINE]Related articles

    9.

    Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.

    Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE.

    J Natl Cancer Inst. 2005 Jan 5;97(1):59-69.PMID: 15632381 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    New primary cancers after squamous cell skin cancer.

    Frisch M, Melbye M.

    Am J Epidemiol. 1995 May 15;141(10):916-22.PMID: 7741121 [PubMed - indexed for MEDLINE]Related articles

    11.

    Nonmelanoma skin cancer and risk for subsequent malignancy.

    Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, Alani R, Liégeois NJ, Hoffman SC, Hoffman-Bolton J, Strickland PT, Helzlsouer KJ, Alberg AJ.

    J Natl Cancer Inst. 2008 Sep 3;100(17):1215-22. Epub 2008 Aug 26.PMID: 18728282 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer.

    Brewster AM, Alberg AJ, Strickland PT, Hoffman SC, Helzlsouer K.

    Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1271-5.PMID: 15298945 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.

    Gao X, Fisher SG, Emami B.

    Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1038-45.PMID: 12829139 [PubMed - indexed for MEDLINE]Related articles

    14.

    Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.

    Nugent Z, Demers AA, Wiseman MC, Mihalcioiu C, Kliewer EV.

    Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2584-90.PMID: 16284382 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Survival after cutaneous metastasis: a study of 200 cases]

    Schoenlaub P, Sarraux A, Grosshans E, Heid E, Cribier B.

    Ann Dermatol Venereol. 2001 Dec;128(12):1310-5. French. PMID: 11908133 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Risk of subsequent cancer following invasive or in situ squamous cell skin cancer.

    Efird JT, Friedman GD, Habel L, Tekawa IS, Nelson LM.

    Ann Epidemiol. 2002 Oct;12(7):469-75.PMID: 12377424 [PubMed - indexed for MEDLINE]Related articles

    18.

    Depression and functional status as predictors of death among cancer patients.

    Stommel M, Given BA, Given CW.

    Cancer. 2002 May 15;94(10):2719-27.PMID: 12173342 [PubMed - indexed for MEDLINE]Related articles

    19.

    Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario.

    Simunovic M, Rempel E, Thériault ME, Coates A, Whelan T, Holowaty E, Langer B, Levine M.

    Can J Surg. 2006 Aug;49(4):251-8.PMID: 16948883 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.

    Hisada M, Chen BE, Jaffe ES, Travis LB.

    J Natl Cancer Inst. 2007 Feb 7;99(3):215-22.PMID: 17284716 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data